Target intelligence / Profile preview

Zinc finger protein 768 (ZNF768)

Target
ZNF768
Molecular classification
Transcription factor, C2H2 zinc finger protein
01

Overview

Zinc finger protein 768 (ZNF768) is a conserved C2H2-type zinc finger transcription factor that plays a critical role in the regulation of cell proliferation, cell fate decisions, and transcriptional networks in mammals[1][2][3][4][5]. ZNF768 is unique among human proteins for its N-terminal heptad-repeat structure, similar to the C-terminal domain of RNA polymerase II, suggesting a specialized transcription regulatory function[5]. It binds sequence-specific DNA, especially mammalian-wide interspersed repeats (MIRs), and predominantly localizes to the nucleus where it regulates the expression of genes involved in cell division and survival[1][3][5]. ZNF768 overexpression supports cell proliferation and represses senescence, acting downstream of oncogenic signaling (such as RAS, via MAPK and PI3K/mTOR pathways)[2][5]. It physically interacts with and inhibits the tumor suppressor p53, allowing cells to bypass cellular senescence and promote tumorigenesis, particularly in lung adenocarcinoma[1][2]. Elevated ZNF768 levels are frequently observed in tumors, and its depletion provokes strong antiproliferative and pro-apoptotic activities. Beyond its role in cancer biology, ZNF768 may serve as a tumor-associated antigen, eliciting autoantibody responses in cancer patients and offering potential in cancer diagnostics[3].

Other names
ZNF768FLJ23436zinc finger protein 768
02

Biological functions

Regulation of transcription by RNA polymerase IIPromotes cell proliferationRepresses cellular senescenceRegulation of cell fate decisionInteraction with tumor suppressor p53 and regulation of p53 signaling
03

Disease associations

Cancer (notably lung adenocarcinoma and potentially other tumor types)Possible immunodiagnostic biomarker in cancer (autoantibody responses in colorectal cancer)
04

Safety considerations

Potential risk of disrupting normal cell proliferation control if therapeutically targeted, as ZNF768 loss leads to increased radiosensitivity, growth defects, and premature senescence in non-cancerous cellsPossible impact on genomic stability and cellular homeostasis due to central role in transcription regulation
05

Biomarkers

ZNF768 expression itself can serve as a biomarker for high proliferative tumors, especially lung adenocarcinomaAssociated with Ki-67, a proliferation marker in tumorsMay have utility as a biomarker of minimally invasive cancer diagnosis due to immunogenicity in cancers (autoantibody response)

Beyond the preview

Go deeper on Zinc finger protein 768 (ZNF768).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 768 (ZNF768).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call